Targeted nanoparticle-based drug delivery and diagnosis

被引：163

作者：

Emerich, Dwaine F. ^{[1
]}

Thanos, Christopher G. ^{[1
]}

机构：

[1] LCT Biopharma, Providence, RI USA

来源：

JOURNAL OF DRUG TARGETING | 2007年 / 15卷 / 03期

关键词：

nanoparticle; drug delivery; targeted delivery; nanomedicine; nanotechnology; molecular diagnostics;

D O I：

10.1080/10611860701231810

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Nanotechnology, or systems/ device manufacture at sizes generally ranging between 1 and 100 nm, is a multidisciplinary scientific field undergoing explosive development. The genesis of nanotechnology can be traced to advances in medicine, communications, genomics and robotics. One of the greatest values of nanotechnology will be in the development of new and effective medical treatments ( i. e. nanomedicine). This review focuses on the potential of nanomedicine as it relates to the development of nanoparticles for enabling and improving the targeted delivery of therapeutic and diagnostic agents. We highlight the use of nanoparticles for specific intra- compartmental analysis using the examples of delivery to malignant cancers, to the central nervous system, and across the gastrointestinal barriers.

引用

页码：163 / 183

页数：21

共 206 条

[1] Nanocrystal targeting in vivo [J].